NASDAQ:ACST
Acasti Pharma Stock News
$2.87
-0.200 (-6.51%)
At Close: Apr 19, 2024
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
08:30am, Wednesday, 09'th Mar 2022
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D'Alvise, President and Chief Executiv
Acasti Pharma Celebrates Rare Disease Day
01:30pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
CEO Jan D’Alvise participates in educational interviews regarding rare diseases, including subarachnoid hemorrhage, ataxia-telangiectasia and postherpetic neuralgia CEO Jan D’Alvise participates i
New Strong Sell Stocks for February 23rd
02:50pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
ARR, ACST, and ATUS have been added to the Zacks Rank #5 (Strong Sell) List on February 23, 2022
New Strong Sell Stocks for February 23rd
11:34am, Wednesday, 23'rd Feb 2022
ARR, ACST, and ATUS have been added to the Zacks Rank #5 (Strong Sell) List on February 23, 2022
Acasti Pharma Inc. (ACST) CEO Jan D''Alvise on Q3 2021 Results - Earnings Call Transcript
09:39pm, Monday, 14'th Feb 2022 Seeking AlphaAcasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript
04:39pm, Monday, 14'th Feb 2022
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript
Acasti Pharma GAAP EPS of -$0.09 misses by $0.01
12:00pm, Monday, 14'th Feb 2022 Seeking Alpha
Acasti Pharma press release (ACST): Q4 GAAP EPS of -$0.09 misses by $0.01.Cash, cash equivalents and short-term investments totaled $46.3 million as of December 31, 2021, compared…
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022
12:00pm, Monday, 14'th Feb 2022 GlobeNewswire Inc.
Provides updates on key milestones: GTX-104 PK study remains on track for results to be reported in the first half of calendar 2022; GTX-102 and GTX-101 progressing on schedule
Earnings Scheduled For February 14, 2022
08:54am, Monday, 14'th Feb 2022 Benzinga
Companies Reporting Before The Bell • Weber (NYSE: WEBR ) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. • Kelly Services (NASDAQ: KELYB ) is expected to report earnings for its fourth quarter. • Westwater Resources (AMEX: WWR ) is likely to report earnings for its fourth quarter. • Scorpio Tankers (NYSE: STNG ) is expected to report quarterly loss at $0.75 per share on revenue of $151.10 million. • Kelly Services (NASDAQ: KELYA ) is expected to report quarterly earnings at $0.28 per share on revenue of $1.30 billion. • Garrett Motion (NASDAQ: GTX ) is projected to report quarterly earnings at $0.19 per share on revenue of $863.00 million. • Applied Genetic (NASDAQ: AGTC ) is expected to report earnings for its second quarter. • Alexander''s (NYSE: ALX ) is projected to report earnings for its fourth quarter. • Acasti Pharma (NASDAQ: ACST ) is estimated to report earnings for its third quarter. • Roivant Sciences (NASDAQ: ROIV ) is estimated to report earnings for its third quarter. • Olink Holding (NASDAQ: OLK ) is expected to report earnings for its fourth quarter. • Treehouse Foods (NYSE: THS ) is likely to report quarterly earnings at $0.09 per share on revenue of $1.12 billion. • Hawaiian Electric Indus (NYSE: HE ) is expected to report quarterly earnings at $0.42 per share on revenue of $681.34 million.
Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call
01:30pm, Monday, 07'th Feb 2022 GlobeNewswire Inc.
Call to be held on Monday, February 14th at 1:00 PM Eastern Time Call to be held on Monday, February 14th at 1:00 PM Eastern Time
Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call
08:30am, Monday, 07'th Feb 2022
Call to be held on Monday, February 14th at 1:00 PM Eastern Time Call to be held on Monday, February 14th at 1:00 PM Eastern Time
Acasti Pharma (ACST) Investor Presentation - Slideshow
08:34pm, Monday, 10'th Jan 2022 Seeking AlphaAcasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference
01:30pm, Monday, 03'rd Jan 2022 GlobeNewswire Inc.
LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and CEO of Aca
Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference
08:30am, Monday, 03'rd Jan 2022
LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D'Alvise, President and CEO of Acasti,